Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis
- 22 July 2013
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 20 (2) , 214-219
Abstract
Background: The accrual of brain focal pathology is considered a good substrate of disability in relapsing–remitting multiple sclerosis (RRMS). However, knowledge on long-term lesion evolution and its relationship with disability progression is poor. Objective: The objective of this paper is to evaluate in RRMS the long-term clinical relevance of brain lesion evolution. Methods: In 58 RRMS patients we acquired, using the same scanner and protocol, brain magnetic resonance imaging (MRI) at baseline and 10±0.5 years later. MRI data were correlated with disability changes as measured by the Expanded Disability Status Scale (EDSS). Results: The annualized 10-year lesion volume (LV) growth was +0.25±0.5 cm3 (+6.7±8.7%) for T2-weighted (T2-W) lesions and +0.20±0.31 cm3 (+11.5±12.3%) for T1-weighted (T1-W) lesions. The univariate analysis showed moderate correlations between baseline MRI measures and EDSS at 10 years ( p < 0.001). Also, 10-year EDSS worsening correlated with LV growth and the number of new/enlarging lesions measured over the same period ( p < 0.005). In the stepwise multiple regression analysis, EDSS worsening over 10 years was best correlated with the combination of baseline T1-W lesion count and increasing T1-W LV ( R = 0.61, p < 0.001). Conclusion: In RRMS patients, long-term brain lesion accrual is associated with worsening in clinical disability. This is particularly true for hypointense, destructive lesions.Keywords
This publication has 20 references indexed in Scilit:
- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisArchives of Neurology, 2012
- Assessing changes in relapse rates in multiple sclerosisMultiple Sclerosis Journal, 2010
- Multiple sclerosis lesions: insights from imaging techniquesExpert Review of Neurotherapeutics, 2009
- Conventional MR ImagingNeuroimaging Clinics Of North America, 2008
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trialThe Lancet Neurology, 2008
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosisBrain, 2008
- Time-Series Modeling of Multiple Sclerosis Disease Activity: A Promising Window on Disease Progression and Repair Potential?Neurotherapeutics, 2007
- A Longitudinal Study of Abnormalities on MRI and Disability from Multiple SclerosisNew England Journal of Medicine, 2002
- Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosisAnnals of Neurology, 1994
- Rating neurologic impairment in multiple sclerosisNeurology, 1983